916985-10-9

Upstream product

• 240420-27-3 methyl (2R)-2-[(tert-butoxycarbonyl)amino]-4-phenylbutanoate 
• 100564-78-1 (2R)-(tert-butoxycarbonylamino)-4-phenylbutanoic acid 

Downstream Products

• 916985-11-0 (R)-tert-butyl 1-(3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl)-3-phenylpropylcarbamate 
• 919529-67-2 C₃₉H₄₂N₄O₆ 
• 916985-12-1 (R)-1-(3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl)-3-phenylpropan-1-amine hydrochloride 

Relevant academic research and scientific papers

GHRELIN MODULATING COMPOUNDS AND COMBINATIONS THEREOF

Compounds that modulate GHS-R are described, for examples compounds formula (I).

HYDRAZIDE CONJUGATES AS IMAGING AGENTS

The present disclosure is directed to diagnostic agents. More specifically, the disclosure is directed to compounds, diagnostic agents, compositions, and kits for detecting and/or imaging and/or monitoring a pathological disorder associated with coronary plaque, carotid plaque, aortic plaque, plaque of the arterial vessel, aneurism, vasculitis, and other diseases of the arterial wall. In addition, the disclosure is directed to methods of detecting and/or imaging and/or monitoring changes in the arterial wall, including expansive and constrictive remodeling, total vessel wall area, internal lumen size, and exterior artery perimeter.

Sulfonamide compounds and uses thereof

Compounds that modulate GHS-R are described, for examples compounds formula (I)